Melissa Clarice Komrosky, NP
Family · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Melissa Clarice Komrosky’s office at (408) 885-5167 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Medicaid work
$0 in 2023
Medicaid paid $0 for 303 billed services this clinician did in 2023, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species, utilizing vaginal-fluid specimens, algorithm reported as a positive or negative result for bacterial vaginosis | 17 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 12 | $0 |
| TREPONEMA PALLIDUM | 40 | $0 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique | 17 | $0 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 86 | $0 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 86 | $0 |
| Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe technique | 17 | $0 |
| Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with screening by automated system and manual rescreening or review, under physician supervision | 12 | $0 |
| Unclassified drugs | 16 | $0 |
| 2023 | 303 | 9 | 23 | $0 |
| 2022 | 1,105 | 19 | 37 | $19,936 |
| 2021 | 3,554 | 27 | 88 | $459,639 |
| 2020 | 653 | 14 | 56 | $48,387 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 40 | $19,936 |
| ELECTROLYTE PANEL | 48 | $0 |
| Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species, utilizing vaginal-fluid specimens, algorithm reported as a positive or negative result for bacterial vaginosis | 52 | $0 |
| Creatinine; blood | 48 | $0 |
| Blood glucose (sugar) level | 48 | $0 |
| Urea nitrogen; quantitative | 48 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 27 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 17 | $0 |
| TREPONEMA PALLIDUM | 100 | $0 |
| HEPATITIS C ANTIBODY | 25 | $0 |
| IAAD IA HEPATITIS B SURFACE ANTIGEN | 25 | $0 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 26 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 945 | $459,639 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 45 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 45 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 27 | $0 |
| ELECTROLYTE PANEL | 12 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 13 | $0 |
| URINE PREGNANCY TEST | 42 | $0 |
| Creatinine; blood | 12 | $0 |
| Blood glucose (sugar) level | 24 | $0 |
| Hemoglobin A1C level | 14 | $0 |
| Urea nitrogen; quantitative | 12 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 50 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 149 | $48,387 |
| ELECTROLYTE PANEL | 14 | $0 |
| Creatinine; blood | 14 | $0 |
| Blood glucose (sugar) level | 14 | $0 |
| Urea nitrogen; quantitative | 14 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 14 | $0 |
| TREPONEMA PALLIDUM | 14 | $0 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 56 | $0 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 56 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 46 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 19 | $0 |
| Short return visit | 66 | $0 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 19 Part D prescriptions in 2018. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2018 | 19 | None | 0% (0) | 58% | $3,342 |
| 2017 | 140 | 63 | None | 14% | $4,163 |
| 2016 | 626 | 101 | 4% (24) | 13% | $19,807 |
| 2015 | 417 | 35 | 3% (11) | None | $10,935 |
| 2014 | 335 | 44 | 4% (12) | None | $10,011 |
| 2013 | 117 | 37 | None | None | $4,240 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2017: 1 drug
| Fluticasone Propionate | 11 | $87 | $8 |
2016: 17 drugs
| Qvar | 13 | $2,654 | $204 |
| Proair Hfa | 12 | $949 | $79 |
| Levothyroxine | 18 | $520 | $29 |
| Hydrocodone-Acetaminophen | 18 | $514 | $29 |
| Atorvastatin | 23 | $359 | $16 |
| Fosinopril | 14 | $256 | $18 |
| Fluticasone Propionate | 29 | $246 | $8 |
| Ibuprofen | 39 | $218 | $6 |
| Omeprazole | 29 | $174 | $6 |
| Gabapentin | 25 | $143 | $6 |
| Metformin | 12 | $143 | $12 |
| Amlodipine Besylate | 23 | $129 | $6 |
| Trazodone | 23 | $126 | $5 |
| Baclofen | 13 | $75 | $6 |
| Alendronate | 14 | $59 | $4 |
| Metoprolol | 15 | $52 | $3 |
| Cyclobenzaprine | 13 | $50 | $4 |
2015: 15 drugs
| Qvar | 16 | $3,768 | $236 |
| Proair Hfa | 12 | $633 | $53 |
| Atorvastatin | 21 | $285 | $14 |
| Fosinopril | 15 | $253 | $17 |
| Ibuprofen | 25 | $177 | $7 |
| Metoprolol | 21 | $160 | $8 |
| Omeprazole | 23 | $154 | $7 |
| Fluticasone Propionate | 13 | $141 | $11 |
| Hydrochlorothiazide | 14 | $131 | $9 |
| Gabapentin | 15 | $131 | $9 |
| Amlodipine Besylate | 15 | $125 | $8 |
| Alendronate | 12 | $120 | $10 |
| Baclofen | 11 | $59 | $5 |
| Lisinopril | 12 | $44 | $4 |
| Cyclobenzaprine | 12 | $37 | $3 |
2014: 10 drugs
| Levothyroxine | 21 | $274 | $13 |
| Cyclobenzaprine | 14 | $235 | $17 |
| Fosinopril | 22 | $224 | $10 |
| Atorvastatin | 13 | $167 | $13 |
| Fluticasone Propionate | 11 | $162 | $15 |
| Metoprolol | 13 | $123 | $9 |
| Ibuprofen | 16 | $95 | $6 |
| Amlodipine Besylate | 11 | $86 | $8 |
| Simvastatin | 11 | $81 | $7 |
| Azithromycin | 11 | $81 | $7 |
Professional record
- NPI
- 1326030867
- Licence
- CA RN 611446
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 16770 Cabernet Cir, Morgan Hill, CA, 95037
- NPI first listed
- 2005-08-19
- NPI last updated
- 2012-02-27
This is when the NPI record was last certified, not a medical board exam.